Skip to main content

Table 1 Socio-demographic and medical characteristics of patients (n = 104)

From: Assessment of psychosocial factors and distress in women having adjuvant endocrine therapy for breast cancer: the relationship among emotional distress and patient and treatment-related factors

Patient factors % (n) Cancer and treatment factors % (n)
Age [mean (min–max)] 52.49 (32–77) Time (months) since AET initiation 24.38 (1–58)
Marital status   Between 1 and 24 months 49 (51)
 Married 75.9 (79) Between 25 and 58 months 51 (53)
 Singlea 24 (25) Current treatment  
Children   Tamoxifenb 47.1 (49)
 One or more 82.7 (86) Aromatase inhibitors (AIs)c 52.9 (55)
 None 17.3 (18) Radiotherapy  
Educational level   Yes 71.2 (74)
 Primary or secondary school 33.7 (35) No 28.8 (30)
 High school 32.7 (34) Chemotherapy  
 College or above 33.7 (35) Yes 61.5 (64)
Socioeconomic status   No 38.5 (40)
 Low 17.3 (18) Pathological tumor stage  
 Middle 70.2 (73) T1 40.4 (42)
 High 12.5 (13) T2 51 (53)
Body mass index (kg/m2)   T3 8.7 (9)
 ≤ 24.9 31.7 (33) Histological grade  
 25–29.9 40.4 (42) Grade I 11.5 (12)
 ≥30 27.9 (29) Grade II 49 (51)
Menopausal status   Grade III 39.4 (41)
 Pre-menopausal 46.2 (48) Type of surgery  
 Peri or post-menopausal 53.8 (56) Mastectomy 56.7 (59)
   Breast conserving surgery 43.3 (45)
  1. aIncludes single, divorced, separated, widower
  2. b2 patients used aromatase inhibitors then switched tamoxifen
  3. cAIs includes anastrozole and letrozole; 4 patients used tamoxifen then switched to AIs